Cue Biopharma, Inc.
NASDAQ:CUE
1.22 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Cue Biopharma, Inc. |
Symbool | CUE |
Munteenheid | USD |
Prijs | 1.22 |
Beurswaarde | 77,287,366 |
Dividendpercentage | 0% |
52-weken bereik | 0.45 - 3.03 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Daniel R. Passeri J.D., M.Sc., MSc. |
Website | https://www.cuebiopharma.com |
An error occurred while fetching data.
Over Cue Biopharma, Inc.
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)